Selected Grants
Eastern North Carolina and southern Virginia regIonal Stroke trIal cONsortium (ENVISION)
ResearchCollaborator · Awarded by National Institutes of Health · 2023 - 2028A multicenter, international, randomized, placebo controlled, double-blind, parallel group and event driven Phase 3 study of the oral FXIa inhibitor asundexian (BAY 2433334) for the prevention of isch
Clinical TrialPrincipal Investigator · Awarded by Bayer Healthcare Pharmaceuticals Inc · 2023 - 2027Cardioembolism as a Mechanism of Central Retinal Artery Occlusion
ResearchPrincipal Investigator · Awarded by National Heart, Lung, and Blood Institute · 2022 - 2027MARS: The Migraine and Retinal Stroke (MARS) Study
ResearchPrincipal Investigator · Awarded by American Heart Association · 2023 - 2025Fellowships, Gifts, and Supported Research
Initial & Outgoing Analysis of Get With The Guidelines Data ·
September 2021
Clinical Lead ·
Awarded by: American Heart Association/American Stroke Association
External Relationships
- Sanofi
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.